Skyrizi had an estimated national TV ad spend of $367.7 million — the highest ad spend of any brand in the top 10.

Skyrizi is used to treat certain inflammatory conditions, such as plaque psoriasis. The drug starts working after your first dose. Skyrizi is approved by the Food and Drug Administration (FDA ...

Lilly already sells several treatments for inflammatory conditions like arthritis and psoriasis ... in combining its ...

Even after a flurry of corporate updates during the first two days of the J.P. Morgan Healthcare Conference, many more ...

However, the analyst wrote in a client note Tuesday, icotrokinra seems less effective than Skyrizi and Tremfya ... or IGA, and the Psoriasis Area and Severity Index, or PASI.

ORKA-001 distinguishes itself from existing treatments such as SKYRIZI through its innovative ... candidate in the competitive landscape of psoriasis treatments, supporting the Buy rating and ...